WO2003028808A2 - Pre-loaded needle assembly - Google Patents

Pre-loaded needle assembly Download PDF

Info

Publication number
WO2003028808A2
WO2003028808A2 PCT/US2001/027780 US0127780W WO03028808A2 WO 2003028808 A2 WO2003028808 A2 WO 2003028808A2 US 0127780 W US0127780 W US 0127780W WO 03028808 A2 WO03028808 A2 WO 03028808A2
Authority
WO
WIPO (PCT)
Prior art keywords
cannula
distal end
plug
assembly
seeds
Prior art date
Application number
PCT/US2001/027780
Other languages
French (fr)
Other versions
WO2003028808A3 (en
Inventor
Gary A. Lamoureux
Richard A. Terwilliger
Original Assignee
Lamoureux Gary A
Terwilliger Richard A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22914698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2003028808(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lamoureux Gary A, Terwilliger Richard A filed Critical Lamoureux Gary A
Priority to EP01274522A priority Critical patent/EP1377342A4/en
Publication of WO2003028808A2 publication Critical patent/WO2003028808A2/en
Publication of WO2003028808A3 publication Critical patent/WO2003028808A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1027Interstitial radiation therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1007Arrangements or means for the introduction of sources into the body
    • A61N2005/1011Apparatus for permanent insertion of sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019Sources therefor
    • A61N2005/1023Means for creating a row of seeds, e.g. spacers

Definitions

  • This invention relates to a needle assembly for implanting therapeutic elements. More' specifically, this invention relates to such an assembly which allows the user to load and place radioactive "seeds" in the body for the purpose of treating cancer.
  • radioactive sources or “seeds” are placed into the body using multiple hollow needles or needle assemblies .
  • the needles act as holders and carriers of such seeds until the needles are inserted into predetermined areas of the body. Once the needles are positioned, the seeds are deployed from each hollow needle by a solid wire stylet to permanently reside in the body as the radioactive dose decays over the treatment time. As many as 25 or more needles are used in each procedure. Typically, a physicist must prepare the needles or cannula and load the seed sources and spacers into each cannula prior to the procedure . Bone wax has been used to close the end of the cannula.
  • the wax is placed into the first 2-5mm of the distal tip of the cannula to prevent the radioactive "seeds" from dislodging or falling out prior to insertion of the cannula into the body.
  • the doctor then inserts the cannulas into the patient and deploys the seeds into the area to be treated.
  • Prior art needle assemblies disclose a cannula with a sharpened distal tip and an inner solid wire stylet that is used to push the radioactive seeds into the body.
  • the proximal end of the cannula consists of a plastic or metal hub that allows the loading of the radioactive seeds into the cannula.
  • the proximal end of the stylet is a plastic or metal handle for manipulation of the stylet.
  • the prior art devices are prepared for use by plugging the end of the cannula with bone wax.
  • the bone wax extends into the first 2-5mm of the distal tip of the cannula to contain the seeds and to prevent body fluids from entering the cannula before deployment of the seed.
  • the bone-wax-plugged cannula is loaded with radioactive seeds held apart by short non-radioactive spacers that position the seeds in the body to achieve an even distribution of radiation to treat the suspected cancer in vivo .
  • the stylet Prior to insertion, the stylet is axially introduced into the proximal end of the cannula and rests upon the stack of seeds and spacers, which are held in place by the bone wax at the distal tip of the needle. Once the cannula is inserted into the body to the proper position, the stylet is eld firm and the cannula is axially moved toward the proximal end of the stylet. This motion deposits the radioactive seeds and
  • Radioactive seeds There are two principal types of radioactive seeds . “Free” seeds are individual radioactive seeds that are loaded in the cannula with small cylindrical spacers stacked in between the radioactive seeds . The second type is a pre- manufactured "strand" of radioactive seeds that are encapsulated in a biodegradable material that spaces the radioactive seeds apart from one another.
  • Bone wax has many drawbacks :
  • Bone wax cannot be applied into the distal end of the cannula in a manner which assures a consistent positioning of the first seed in the cannula .
  • the amount of wax varies needle to needle .
  • Bone wax is sticky and difficult to apply.
  • Bone wax may cause the first few seeds being deployed to stick to the end of the cannula as it is being withdrawn, displacing them from their intended position in the treated tissue (adjacent the prostate, for instance) .
  • the needle assembly of the invention comprises a needle which may be delivered to the user already loaded and sterile . This reduces preparation time as well as personal exposure to the radioactive seeds .
  • the needle assembly of the invention exactly locates the first seed a repeatable and known distance from the distal end of the cannula in each needle used thus improving the accuracy of placing the radioactive seeds in the body.
  • the positioning means for the first seed may take one of a variety of forms, all of them yieldable to permit the seed to be pushed past the distal end in the implantation.
  • the needle assembly of the invention may include a biocompatable end plug which may be made of a variety of materials including absorbable or non-absorbable suture materials either in a braided or monofilament configuration or molded biocompatable polymer .
  • the plug may be held in place by a mechanical
  • This detail may be formed by parallel slits in the body of the cannula, a "U" shaped cutout in the cannula creating a
  • holding the biocompatable end plug in place inside the cannula at the distal end of the cannula may be accomplished by modifying the diameter of the plug by mechanical distortion means or expanding the diameter of the plug by heating the material until it
  • the stylet of the inventive needle may be provided in a hollow tubular form.
  • the tube used in the stylet extends through the stylet handle to create an air passageway.
  • This hollow stylet is provided to prevent air pressure from building up inside of the cannula caused by the tight fit of the stylet and the interior diameter of the cannula. This buildup of air pressure may cause premature dislodging of the seed
  • the hollow stylet can capture the tail end of the encapsulated strand and prevent the tail end from becoming entrapped between the inner diameter of the cannula and the outer diameter of the stylet during its deployment.
  • the invention for implanting a therapeutic element, is a needle assembly comprising a cannula having a sharpened distal end, a line of elements in the cannula extending rearward from the distal end and yeildable means for positioning the element more proximate the distal end a predetermined distance from the distal end.
  • the assembly also includes a stylet reciprocable in the cannula and engaging the end of the line of elements more remote from the distal end of the cannula .
  • Fig. 1 is a side view with the cannula partly broken away of a preferred needle assembly embodying the invention .
  • Fig. 2 is a fragmentary enlarged view partly exploded, of the distal end of the assembly.
  • Fig. 3 is a side view with the cannula partly broken away showing use with an encapsulated line of seeds .
  • Fig. 4 is a fragmentary enlarged view, partly exploded, of the distal end of the assembly of Fig- 3.
  • Figs . 5a, 5b and 5c are enlarged fragmentary top, bottom and sectional views respectively of the preferred embodiment.
  • Figs . 6a, 6b and 6c are enlarged fragmentary top, bottom and sectional views . respectively .of a modified form of the invention .
  • Fig. 6d is similar to Fig. 5c but showing the combination with an end plug
  • Figs. 7a, 7b and 7c are fragmentary top, bottom and sectional views respectively of a further modified form of the inventio .
  • FIG. 1 A preferred embodiment of needle assembly of the invention is shown in Fig. 1 and generally designated 10. It comprises a cannula 12 having a hub 14 formed with gripping surfaces 14a.
  • the cannula has a tubular body 16 broken away in Fig. 1 to show its contents and a sharpened distal end 18 beveled off at 20 to provide a point 20a.
  • Reciprocably disposed in the cannula is the wire stylet 22 having an handle 24 it its proximate end.
  • the distal end of the stylet comprises an engagement surface 26.
  • a line of therapeutic elements for instance, radioactive seeds 28.
  • the seeds 28 are disposed within the cannula.
  • the seeds 28 are also disposed within the cannula.
  • spacers 30 of cylindrical shape and made of a biocompatable and biodegradable material such as catgut alternate with spacers 30 of cylindrical shape and made of a biocompatable and biodegradable material such as catgut.
  • An end plug 32 is disposed at the distal end of the cannula.
  • the end plug comprises a rearward cylindrical end surface 32a (Fig. 2) which is positioned at an exact length back from the extreme distal end of the tip 20a of the beveled point 20. This distance is critical and it does not vary from assembly-to-assembly.
  • the means by which the end plug 32 is positioned in the cannula with its end surface 32a at the pre-determined distance back may be based on one of a variety of structures and techniques.
  • the material of the end plug is again biocompatable and biodegradable. It may be formed, for instance, of processed collagen (catgut) , Nylon or various other organic substances .
  • a preferred material is polyglactin acid (PGA) available under the trademark POLYGLACTIN 910.
  • the end plug 32 may be_positioned as a friction fit pressed into the distal end of the cannula as a cork in a bottle. Alternatively, it may be treated with a solvent so that it adheres to the inside of the cannula wall . By another technique it may be put in position and the cannula heated to cause the end plug to swell and hold its position. As an additional variation, the cannula may be infinitesimally distorted externally to cause it to "shrink" in the area of the plug and thereby hold the plug in position.
  • the end plug is yieldably held in precise position and may be forced out- ward as the cannula is drawn backward on the stylet.
  • the positioning of the end plug 32 in the cannula 12 is yieldable.
  • the plug seals the needle and keeps the seeds from spilling out the needle or body fluids from entering the needle prematurely.
  • the needle assembly is inserted in the tissue of the body to be treated, distal end first.
  • the stylet 22 is held firmly and the cannula is drawn back toward the handle 24 of the stylet causing the end plug 32 to give way from its initial position and deposit in the tissue the line of seeds and spacers . This operation leaves the seeds in the exact desired position in the body.
  • Figs . 3 and 4 show a similar arrangement of the plug 132 -numerals augmented by 100 are used to designate corresponding parts— in the cannula 112 , but instead of the line of seeds and spacers 28, 30, there is the encapsulated line of seeds 128 connected by spacing webs 131.
  • the stylet 122 may be provided with a cylindrical recess 150 to receive the tail 152 on the proximate end of the encapsulated seeds.
  • the cylinder recess 150 may be extended rearwardly in the form of a vent 154 which extends all the way to the end of the stylet.
  • a vent 154 which extends all the way to the end of the stylet.
  • Such an axial vent of the stylet is also contemplated for the Figs . 1 and 2 and other embodiments .
  • the purpose of the vent as stated is to prevent a pressure build-up as the stylet is introduced into the cannula. Such pressure can result from the close fitting nature of the stylet in the cannula and can have the effect of a piston in a cylinder pumping inadvertent pressure on the line of seeds and spacers 28, 30 to move them prematurely.
  • Figs. 5a, 5b and 5c are enlarged views of the distal end of the cannula in the Figs. 1, 2 embodiment.
  • Fig. 5a a sectional view shows the plug 32 in place with the seeds 28 and spacers 30 lined up behind it.
  • the plug 32 may be a friction fit or may be held in place by a solvent coating
  • the first seed 28 is held in place by a tongue 212a which is formed from a U-shaped incision (Fig. 6) 214 wherein the legs "U" are longitudinal of the cannula 212.
  • the cannula wall portion between the legs is bent inward of the cannula so that the distal end of the tongue engages the first seed 28 (Fig. 6c) and yieldably holds it in place.
  • the pressure on the line of seeds will cause the tongue 212a to yield and permit the first seed 28 in the line of spacers and seeds thereafter to move past the tongue and assume their proper place in the tissue.
  • the first seed 28 is positioned precisely, but rather than by the rear surface of a end plug, it is by distortion of the cannula itself, namely, the tongue 212a which engages the first seed 28.
  • the end plug 232 is engaged by the tongue 212a and the plug, rather than the seed 28, is yieldably held in position with the rear surface 232a of the plug in the exact pre-determined position in the cannula back from the point 220a.
  • the cannula 312 is formed adjacent the distal end 318 with a pair of spaced openings 360 and 362.
  • a bridge 364 in the cannula wall between the openings 360 and 362 is deflected inward in U-shape (Fig. 7 ⁇ ) to frictionally engage the plug 332 and hold the plug yieldably in place until it is pressed outward by the first seed 28.
  • the rearward surface 332a is the means for precise positioning of the forward end of the first seed.
  • the positioning of the first seed 28 is , consistently established by the surface against which it abuts .
  • the abutment surface is in the form of the rear surface of a plug, but, as in the Fig. 6c arrangement, the positioning of the lead end of the first seed 28 may be a mechanical yieldable portion of the cannula itself.
  • Further variations in the invention are possible.
  • the invention has been shown but in a few forms, it is not so limited but is of a scope defined by the following claim language which may be broadened by an extension of the right to exclude others from making, using or selling the invention as is appropriate under the doctrine of equivalents

Abstract

A needle assembly (10) including a cannula (12) having a sharpened distal end (20a), a line of elements (28) n the cannula (12) extending reward from the distal end (20a). A yieldable positioner (32) positions the elements (28) more proximate the distal end (20a). The positioner (32) may be in various forms including a plug (32), a tab (214) in the cannula (12) and a distortion (364). A stylet (22) engages the line of elements (28).

Description

PRE-LOADED NEEDLE ASSEMBLY
This application is related to Provisional patent application S.N. 60/242,414 filed October 25, 2000.
FIELD OF THE INVENTION
This invention relates to a needle assembly for implanting therapeutic elements. More' specifically, this invention relates to such an assembly which allows the user to load and place radioactive "seeds" in the body for the purpose of treating cancer.
BACKGROUND OF THE INVENTION
The placement of a pattern of radioactive sources in the body to treat cancer by destroying cancer cells with low dose radiation is an accepted and preferred method of treatment as an alternative to general surgery.
These radioactive sources or "seeds" are placed into the body using multiple hollow needles or needle assemblies . The needles act as holders and carriers of such seeds until the needles are inserted into predetermined areas of the body. Once the needles are positioned, the seeds are deployed from each hollow needle by a solid wire stylet to permanently reside in the body as the radioactive dose decays over the treatment time. As many as 25 or more needles are used in each procedure. Typically, a physicist must prepare the needles or cannula and load the seed sources and spacers into each cannula prior to the procedure . Bone wax has been used to close the end of the cannula. The wax is placed into the first 2-5mm of the distal tip of the cannula to prevent the radioactive "seeds" from dislodging or falling out prior to insertion of the cannula into the body. The doctor then inserts the cannulas into the patient and deploys the seeds into the area to be treated.
Prior art needle assemblies disclose a cannula with a sharpened distal tip and an inner solid wire stylet that is used to push the radioactive seeds into the body. The proximal end of the cannula consists of a plastic or metal hub that allows the loading of the radioactive seeds into the cannula.
The proximal end of the stylet is a plastic or metal handle for manipulation of the stylet.
The prior art devices are prepared for use by plugging the end of the cannula with bone wax. The bone wax extends into the first 2-5mm of the distal tip of the cannula to contain the seeds and to prevent body fluids from entering the cannula before deployment of the seed. The bone-wax-plugged cannula is loaded with radioactive seeds held apart by short non-radioactive spacers that position the seeds in the body to achieve an even distribution of radiation to treat the suspected cancer in vivo .
Prior to insertion, the stylet is axially introduced into the proximal end of the cannula and rests upon the stack of seeds and spacers, which are held in place by the bone wax at the distal tip of the needle. Once the cannula is inserted into the body to the proper position, the stylet is eld firm and the cannula is axially moved toward the proximal end of the stylet. This motion deposits the radioactive seeds and
spacers into the body in a track or line of seeds as the cannula is pulled back.
There are two principal types of radioactive seeds . "Free" seeds are individual radioactive seeds that are loaded in the cannula with small cylindrical spacers stacked in between the radioactive seeds . The second type is a pre- manufactured "strand" of radioactive seeds that are encapsulated in a biodegradable material that spaces the radioactive seeds apart from one another.
The complications involved in the prior art stem from the use of bone wax or other materials that are used to plug the cannulas prior to the loading of the radioactive seeds .
Bone wax has many drawbacks :
1. Bone wax cannot be applied into the distal end of the cannula in a manner which assures a consistent positioning of the first seed in the cannula . The amount of wax varies needle to needle .
2. Bone wax is sticky and difficult to apply.
3. Bone wax may cause the first few seeds being deployed to stick to the end of the cannula as it is being withdrawn, displacing them from their intended position in the treated tissue (adjacent the prostate, for instance) .
4. If the seeds and spacers must be removed after initial loading to change the pattern of seeds and spacers in a given needle, the bone wax prevents the unloading of the
« seeds in contact with the wax.- This prevents the needle from being able to be reused in the procedure.
SUMMARY OF THE INVENTION
The needle assembly of the invention comprises a needle which may be delivered to the user already loaded and sterile . This reduces preparation time as well as personal exposure to the radioactive seeds .
The needle assembly of the invention exactly locates the first seed a repeatable and known distance from the distal end of the cannula in each needle used thus improving the accuracy of placing the radioactive seeds in the body. The positioning means for the first seed may take one of a variety of forms, all of them yieldable to permit the seed to be pushed past the distal end in the implantation.
The needle assembly of the invention may include a biocompatable end plug which may be made of a variety of materials including absorbable or non-absorbable suture materials either in a braided or monofilament configuration or molded biocompatable polymer . In one embodiment of the invention, the plug may be held in place by a mechanical
_ detail proximal to the distal end of the cannula.
This detail may be formed by parallel slits in the body of the cannula, a "U" shaped cutout in the cannula creating a
"tongue" that can be displaced into the interior of the cannula, or small holes that pierce the tubular body of the cannula leaving a web between the holes . In each instance the
"web" of needle material created by the hole or slitting process in the tubular body of the cannula allows for a predetermined sizing of the inner diameter of the cannula to
hold the end plug or seeds in place prior to deploying them into the body.
In an alternate embodiment of the invention, holding the biocompatable end plug in place inside the cannula at the distal end of the cannula may be accomplished by modifying the diameter of the plug by mechanical distortion means or expanding the diameter of the plug by heating the material until it
* swells or exposing the plug to solvents .
By enlarging the diameter of the biocompatable end plug, there is created a tight fit between the plug and the cannula body at the distal tip.
The stylet of the inventive needle may be provided in a hollow tubular form. The tube used in the stylet extends through the stylet handle to create an air passageway. This hollow stylet is provided to prevent air pressure from building up inside of the cannula caused by the tight fit of the stylet and the interior diameter of the cannula. This buildup of air pressure may cause premature dislodging of the seed
source as the stylet is introduced into the cannula after loading and prior to expulsion of the seeds .in the body.
In the case of encapsulated seed sources , the hollow stylet can capture the tail end of the encapsulated strand and prevent the tail end from becoming entrapped between the inner diameter of the cannula and the outer diameter of the stylet during its deployment.
In essence, for implanting a therapeutic element, the invention is a needle assembly comprising a cannula having a sharpened distal end, a line of elements in the cannula extending rearward from the distal end and yeildable means for positioning the element more proximate the distal end a predetermined distance from the distal end. The assembly also includes a stylet reciprocable in the cannula and engaging the end of the line of elements more remote from the distal end of the cannula .
BRIEF DESCRIPTION OF THE DRAWINGS Further objects and features of the invention will be clear to those skilled in the art from a review of the following specification and drawings , all of which present a non- limiting form of the invention. In the drawings :
Fig. 1 is a side view with the cannula partly broken away of a preferred needle assembly embodying the invention .
Fig. 2 is a fragmentary enlarged view partly exploded, of the distal end of the assembly.
Fig. 3 is a side view with the cannula partly broken away showing use with an encapsulated line of seeds .
Fig. 4 is a fragmentary enlarged view, partly exploded, of the distal end of the assembly of Fig- 3.
Figs . 5a, 5b and 5c are enlarged fragmentary top, bottom and sectional views respectively of the preferred embodiment.
Figs . 6a, 6b and 6c are enlarged fragmentary top, bottom and sectional views . respectively .of a modified form of the invention .
Fig. 6d is similar to Fig. 5c but showing the combination with an end plug, and
Figs. 7a, 7b and 7c are fragmentary top, bottom and sectional views respectively of a further modified form of the inventio .
DESCRIPTION OF THE ' PREFERRED AND OTHER EMBODIMENTS
«
A preferred embodiment of needle assembly of the invention is shown in Fig. 1 and generally designated 10. It comprises a cannula 12 having a hub 14 formed with gripping surfaces 14a. The cannula has a tubular body 16 broken away in Fig. 1 to show its contents and a sharpened distal end 18 beveled off at 20 to provide a point 20a.
Reciprocably disposed in the cannula is the wire stylet 22 having an handle 24 it its proximate end. The distal end of the stylet comprises an engagement surface 26.
Also disposed within the cannula is a line of therapeutic elements, for instance, radioactive seeds 28. The seeds 28
alternate with spacers 30 of cylindrical shape and made of a biocompatable and biodegradable material such as catgut.
An end plug 32 is disposed at the distal end of the cannula. The end plug comprises a rearward cylindrical end surface 32a (Fig. 2) which is positioned at an exact length back from the extreme distal end of the tip 20a of the beveled point 20. This distance is critical and it does not vary from assembly-to-assembly.
The means by which the end plug 32 is positioned in the cannula with its end surface 32a at the pre-determined distance back may be based on one of a variety of structures and techniques. To begin with, the material of the end plug is again biocompatable and biodegradable. It may be formed, for instance, of processed collagen (catgut) , Nylon or various other organic substances . A preferred material is polyglactin acid (PGA) available under the trademark POLYGLACTIN 910.
The end plug 32 may be_positioned as a friction fit pressed into the distal end of the cannula as a cork in a bottle. Alternatively, it may be treated with a solvent so that it adheres to the inside of the cannula wall . By another technique it may be put in position and the cannula heated to cause the end plug to swell and hold its position. As an additional variation, the cannula may be infinitesimally distorted externally to cause it to "shrink" in the area of the plug and thereby hold the plug in position.
In all embodiments , no matter by what means , the end plug is yieldably held in precise position and may be forced out- ward as the cannula is drawn backward on the stylet. Thus, the positioning of the end plug 32 in the cannula 12 is yieldable. Before yielding, the plug seals the needle and keeps the seeds from spilling out the needle or body fluids from entering the needle prematurely.
In more detail, in the operation of the needle assembly shown in Figs . 1 and 2 , as with the other embodiments to follow, the needle assembly is inserted in the tissue of the body to be treated, distal end first. When the insertion is to the desired depth, the stylet 22 is held firmly and the cannula is drawn back toward the handle 24 of the stylet causing the end plug 32 to give way from its initial position and deposit in the tissue the line of seeds and spacers . This operation leaves the seeds in the exact desired position in the body.
It will be understood that the exact positioning of the rear end surface 32a at the pre-established distance back from the tip 20a is a significant advance over the haphazard positioning of the more proximate end of a bone wax material as used in the needle assemblies of the prior art. The arrangement of the present disclosure enables the operator to be assured of the precise positioning of the front end of the first seed 28 and the succeeding spaced seeds as they are inserted.
Figs . 3 and 4 show a similar arrangement of the plug 132 -numerals augmented by 100 are used to designate corresponding parts— in the cannula 112 , but instead of the line of seeds and spacers 28, 30, there is the encapsulated line of seeds 128 connected by spacing webs 131.
For the encapsulated seeds versions shown in Figs . 3 and 4, the stylet 122 may be provided with a cylindrical recess 150 to receive the tail 152 on the proximate end of the encapsulated seeds. If desired, the cylinder recess 150 may be extended rearwardly in the form of a vent 154 which extends all the way to the end of the stylet. Such an axial vent of the stylet is also contemplated for the Figs . 1 and 2 and other embodiments . The purpose of the vent as stated is to prevent a pressure build-up as the stylet is introduced into the cannula. Such pressure can result from the close fitting nature of the stylet in the cannula and can have the effect of a piston in a cylinder pumping inadvertent pressure on the line of seeds and spacers 28, 30 to move them prematurely.
Figs. 5a, 5b and 5c are enlarged views of the distal end of the cannula in the Figs. 1, 2 embodiment. Fig. 5a, a sectional view shows the plug 32 in place with the seeds 28 and spacers 30 lined up behind it. As stated, the plug 32 may be a friction fit or may be held in place by a solvent coating
to adhesively fix the plug in place, or by heat or by minute distortions of the cannula.
In the modification of Figs. 6a, 6b and 6c, the first seed 28 is held in place by a tongue 212a which is formed from a U-shaped incision (Fig. 6) 214 wherein the legs "U" are longitudinal of the cannula 212. The cannula wall portion between the legs is bent inward of the cannula so that the distal end of the tongue engages the first seed 28 (Fig. 6c) and yieldably holds it in place. When the cannula is drawn back along the stylet, the pressure on the line of seeds will cause the tongue 212a to yield and permit the first seed 28 in the line of spacers and seeds thereafter to move past the tongue and assume their proper place in the tissue. Thus, in the 6a, 6b and 6c embodiment, the first seed 28 is positioned precisely, but rather than by the rear surface of a end plug, it is by distortion of the cannula itself, namely, the tongue 212a which engages the first seed 28.
In the Fig. 6d variation the end plug 232 is engaged by the tongue 212a and the plug, rather than the seed 28, is yieldably held in position with the rear surface 232a of the plug in the exact pre-determined position in the cannula back from the point 220a.
In the embodiment shown in Figs. 7a, 7b and 7σ, the cannula 312 is formed adjacent the distal end 318 with a pair of spaced openings 360 and 362. A bridge 364 in the cannula wall between the openings 360 and 362 is deflected inward in U-shape (Fig. 7σ) to frictionally engage the plug 332 and hold the plug yieldably in place until it is pressed outward by the first seed 28. Here again, the rearward surface 332a is the means for precise positioning of the forward end of the first seed.
Other variations of the invention are contemplated. In every variation the positioning of the first seed 28 is , consistently established by the surface against which it abuts . Usually the abutment surface is in the form of the rear surface of a plug, but, as in the Fig. 6c arrangement, the positioning of the lead end of the first seed 28 may be a mechanical yieldable portion of the cannula itself. Further variations in the invention are possible. Thus, while the invention has been shown but in a few forms, it is not so limited but is of a scope defined by the following claim language which may be broadened by an extension of the right to exclude others from making, using or selling the invention as is appropriate under the doctrine of equivalents

Claims

WHAT IS CLAIMED IS:
1. For implanting a therapeutic element, a needle assembly comprising a cannula having a sharpened distal end, a line of elements in the cannula extending rearward from the distal end, yieldable means for positioning the element more proximate the distal end a predetermined distance from the distal end, and a stylet reciprocable in the cannula engaging the end of the line of elements more remote from the distal end of the cannula.
2. A needle assembly as claimed in Claim 1 wherein the means for positioning is a plug.
3. An assembly as claimed in Claim 1 wherein the line of seeds is encapsulated, the seeds being held in spaced relation by the encapsulation.
4. An assembly as claimed in Claim 1 wherein the line of seeds has a rearward tail and the distal end of the stylet is formed with an axial recess receiving the tail.
5. An assembly as claimed in Claim 1 wherein the wall of the distal end of the cannula is formed with an irregularity to comprise the means for positioning.
6. An assembly as claimed in Claim 1 wherein the wall is longitudinally slitted at peripherally spaced location and the wall is deflected inward between two adjacent slits to form an inward tabs to comprise the means for positioning.
7. An assembly as claimed in -Claim 6 wherein the inward tab extends inward from the wall of the cannula and has a U- shaped outline .
8. An assembly as claimed in Claim 6 wherein the irregularity is an inward hump in the wall of the cannula between the slits .
9. For implanting a therapeutic element, a needle assembly comprising a cannula having a sharpened distal end, a generally cylindrical end plug frictionally held in the distal end having its rearward end extending from the distal end a pre-determined distance, a line of seeds in the cannula contacting the plug and extending rearward therefrom, and a stylet reciprocable in the cannula engaging the end of the line of seeds more remote from the distal end of the cannula.
10. An assembly as claimed in Claim 9 wherein the line of elements is encapsulated, the seeds being held in spaced relation by the encapsulation.
11. An assembly as claimed in Claim 9 wherein the line of elements has a rearward tail and the distal end of the stylet is ormed with an axial recess receiving the tail .
12. An assembly as claimed in Claim 9 wherein the wall of the distal end of the cannula is formed with an irregularity to enhance the frictional holding of the plug.
13. An assembly as claimed in Claim 12 wherein the irregularity is in the form of a tab extending inward of the wall.
14. An assembly as claimed in Claim 12 wherein the wall is formed with peripherally spaced openings and an inward hump is deflected inward between the openings to comprise the irregularity.
15. An assembly as claimed in Claim 9 wherein the stylet is formed with an axial vent.
16. A method of making a needle assembly for implanting radiation seeds, comprising the steps of: a. providing a cannula having a sharpened distal end and a generally cylindrical plug, b. forcing the plug into the distal end of the cannula to frictionally reside there.
17. A method of making a needle assembly for implanting therapeutic elements, comprising the steps of: a. providing a cannula having a sharpened distal end and a generally cylindrical plug, b. placing the plug into the distal end of the cannula to reside there, and c. modifying the diameter of the plug to enhance its frictional engagement with the contiguous wall of the cannula.
18. A method as claimed in Claim 17 wherein the diameter is modified by heating.
19. A method as claimed in Claim 17 wherein the diameter of the plug is modified by treating the plug with a -solvent.
20. A method as claimed in Claim 17 wherein the diameter of the plug is modified by mechanical distortion .
PCT/US2001/027780 2000-10-25 2001-10-24 Pre-loaded needle assembly WO2003028808A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP01274522A EP1377342A4 (en) 2000-10-25 2001-10-24 Pre-loaded needle assembly

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24241400P 2000-10-25 2000-10-25
US60/242,414 2000-10-25

Publications (2)

Publication Number Publication Date
WO2003028808A2 true WO2003028808A2 (en) 2003-04-10
WO2003028808A3 WO2003028808A3 (en) 2003-10-30

Family

ID=22914698

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/027780 WO2003028808A2 (en) 2000-10-25 2001-10-24 Pre-loaded needle assembly

Country Status (3)

Country Link
US (1) US6554760B2 (en)
EP (1) EP1377342A4 (en)
WO (1) WO2003028808A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223226B2 (en) 2004-11-05 2007-05-29 Nuclear Consultants Group, Inc. Brachytherapy needle and methods for assembling same
WO2011079220A1 (en) * 2009-12-23 2011-06-30 Medi-Physics, Inc. Brachytherapy kit
WO2011079168A1 (en) * 2009-12-23 2011-06-30 Medi-Physics, Inc. Plugless brachytherapy needle
CN104688283A (en) * 2015-03-17 2015-06-10 无锡市人民医院 Accurately-positioning minimally-invading planter

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US20090030309A1 (en) * 2007-07-26 2009-01-29 Senorx, Inc. Deployment of polysaccharide markers
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
US6450939B1 (en) * 2000-11-06 2002-09-17 Peter D. Grimm Hinged spacer element for joining radioactive seeds used in treatment of cancer
EP1545705A4 (en) 2000-11-16 2010-04-28 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
CA2659518A1 (en) 2000-11-20 2002-05-30 Senorx, Inc. Tissue site markers for in vivo imaging
US7497862B2 (en) * 2001-08-03 2009-03-03 Tyco Healthcare Group Lp Tissue marking apparatus and method
US7060020B2 (en) 2001-11-02 2006-06-13 Ideamatrix, Inc. Delivery system and method for interstitial radiation therapy
US7074291B2 (en) * 2001-11-02 2006-07-11 Worldwide Medical Technologies, L.L.C. Delivery system and method for interstitial radiation therapy using strands constructed with extruded strand housings
US20030225437A1 (en) * 2002-04-04 2003-12-04 Ferguson Patrick J. Device for retaining material
US6837844B1 (en) 2002-05-14 2005-01-04 Med-Tec Iowa, Inc. Seed cartridge for radiation therapy
US6840899B2 (en) * 2002-08-29 2005-01-11 Kinamed, Inc. Method and instrument for surgical delivery of biocompatible materials
DE60324448D1 (en) * 2002-09-10 2008-12-11 Cianna Medical Inc brachytherapy
US7041047B2 (en) * 2002-10-04 2006-05-09 Boston Scientific Scimed, Inc. Method and apparatus for the delivery of brachytherapy
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US6969344B2 (en) 2003-02-10 2005-11-29 Bard Brachytherapy, Inc. End portion of first implantation seed spacer that receives and holds any one of implantation seed and second implantation seed spacer
US7037252B2 (en) * 2003-05-05 2006-05-02 Draxis Specialty Pharmaceuticals, Inc. Brachytherapy seed transport devices and methods for using same
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050113855A1 (en) * 2003-08-11 2005-05-26 Kennedy Kenneth C.Ii Surgical implant
US20050245785A1 (en) * 2003-10-29 2005-11-03 Tarone Theodore T Biodegradable seed placement device and method
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US7465279B2 (en) * 2004-03-31 2008-12-16 Ethicon Endo-Surgery, Inc. Marker device and method of deploying a cavity marker using a surgical biopsy device
US7351192B2 (en) * 2004-05-25 2008-04-01 Core Oncology, Inc. Selectively loadable/sealable bioresorbable carrier assembly for radioisotope seeds
US7588528B2 (en) * 2004-08-24 2009-09-15 C. R. Bard, Inc. Brachytherapy apparatus for dispensing medication
US7361135B2 (en) * 2004-08-24 2008-04-22 C R Bard, Inc Brachytherapy system for dispensing medication
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US7736293B2 (en) * 2005-07-22 2010-06-15 Biocompatibles Uk Limited Implants for use in brachytherapy and other radiation therapy that resist migration and rotation
US8187159B2 (en) 2005-07-22 2012-05-29 Biocompatibles, UK Therapeutic member including a rail used in brachytherapy and other radiation therapy
US20070078291A1 (en) * 2005-09-30 2007-04-05 North American Scientific Needle assembly with enhanced steerability
US8052658B2 (en) 2005-10-07 2011-11-08 Bard Peripheral Vascular, Inc. Drug-eluting tissue marker
US8137256B2 (en) * 2005-12-16 2012-03-20 Portola Medical, Inc. Brachytherapy apparatus
US20070270627A1 (en) * 2005-12-16 2007-11-22 North American Scientific Brachytherapy apparatus for asymmetrical body cavities
US20080230001A1 (en) * 2006-02-23 2008-09-25 Meadwestvaco Corporation Method for treating a substrate
US7988611B2 (en) 2006-05-09 2011-08-02 Biocompatibles Uk Limited After-loader for positioning implants for needle delivery in brachytherapy and other radiation therapy
NL1031786C1 (en) * 2006-05-10 2007-11-13 Isodose Control Intellectual P Catheter needle for internal irradiation of a tumor in a body part.
US8668676B2 (en) * 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
US20090216063A1 (en) * 2008-01-29 2009-08-27 Biocompatibles Uk Limited Bio-absorbable brachytherapy strands
US9039761B2 (en) * 2006-08-04 2015-05-26 Allergan, Inc. Ocular implant delivery assemblies with distal caps
US7874976B1 (en) 2006-09-07 2011-01-25 Biocompatibles Uk Limited Echogenic strands and spacers therein
US7878964B1 (en) 2006-09-07 2011-02-01 Biocompatibles Uk Limited Echogenic spacers and strands
US8064987B2 (en) 2006-10-23 2011-11-22 C. R. Bard, Inc. Breast marker
WO2008058089A2 (en) * 2006-11-03 2008-05-15 North American Scientific, Inc. Brachytherapy device having seed tubes with individually-settable tissue spacings
EP3542748B1 (en) 2006-12-12 2023-08-16 C. R. Bard, Inc. Multiple imaging mode tissue marker
ES2432572T3 (en) 2006-12-18 2013-12-04 C.R. Bard, Inc. Biopsy marker with imaging properties generated in situ
US20080208223A1 (en) * 2007-02-26 2008-08-28 Paul Edward Kraemer Cable clamping device and method of its use
US8311610B2 (en) 2008-01-31 2012-11-13 C. R. Bard, Inc. Biopsy tissue marker
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US8670818B2 (en) 2008-12-30 2014-03-11 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US8545554B2 (en) * 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
WO2011038080A2 (en) * 2009-09-25 2011-03-31 Pharmaseq, Inc. Apparatus and method to deliver a microchip
WO2012024085A2 (en) * 2010-08-20 2012-02-23 Wake Forest University Health Sciences Tethered and/or visually coded brachytherapy devices and related methods
US20150080845A1 (en) * 2013-03-14 2015-03-19 Allergan, Inc. Polymer system for securing implants in syringe needles
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
US11133866B2 (en) 2014-02-25 2021-09-28 Pharmaseq, Inc. All optical identification and sensor system with power on discovery
RU2728195C2 (en) 2014-02-26 2020-07-28 Аллерган, Инк. Device for delivery of intraocular implant and methods of its use
FR3018196A1 (en) * 2014-03-10 2015-09-11 Andriy Bondaryev E12-ENDOSCOPIC NEEDLE I125 RADIOACTIVE SOURCE APPLICATOR FOR ENDOBRACHYTHERAPY OF MALIGNANT TUMORS
US10882258B1 (en) 2016-01-22 2021-01-05 Pharmaseq, Inc. Microchip affixing probe and method of use
US20180289467A1 (en) * 2017-04-05 2018-10-11 Ernesto Andrade Dispensing device, kit, and method for tissue augmentation
EP3703804B1 (en) 2017-11-02 2022-02-16 IsoRay Medical, Inc. Device for loading brachytherapy seeds into implantation sleeves
US11546129B2 (en) 2020-02-14 2023-01-03 P-Chip Ip Holdings Inc. Light-triggered transponder

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460592A (en) * 1994-01-24 1995-10-24 Amersham Holdings, Inc. Apparatus and method for making carrier assembly for radioactive seed carrier
US6450937B1 (en) * 1999-12-17 2002-09-17 C. R. Bard, Inc. Needle for implanting brachytherapy seeds
US6450938B1 (en) * 2000-03-21 2002-09-17 Promex, Llc Brachytherapy device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2269963A (en) 1940-06-01 1942-01-13 Wappler Frederick Charles Implanting device
US2761446A (en) 1955-03-30 1956-09-04 Chemical Specialties Co Inc Implanter and cartridge
US3224432A (en) 1963-04-10 1965-12-21 Frank S Billingsley Device for irradiating a body cavity
US4235244A (en) 1978-07-27 1980-11-25 Medi-Tech, Incorporated Microbiological specimen sampling device
FR2432456A1 (en) * 1978-07-31 1980-02-29 Cassou Robert Single piece tube pack of pharmaceutical esp. veterinary pellets - retains pellets with interior elastic lip at open end of tube
US4490139A (en) 1983-01-28 1984-12-25 Eli Lilly And Company Implant needle and method
US5310407A (en) 1991-06-17 1994-05-10 Datascope Investment Corp. Laparoscopic hemostat delivery system and method for using said system
US5484403A (en) 1994-04-05 1996-01-16 Avid Marketing, Inc. Hypodermic syringe for implanting solid objects
MY128127A (en) * 1998-04-23 2007-01-31 Alza Corp Trocar for inserting implants
WO2000004953A2 (en) * 1998-07-20 2000-02-03 Cook Urological Inc. Brachytherapy device including an anti-static handle
US6537192B1 (en) 2000-06-05 2003-03-25 Mentor Corporation Automated radioisotope seed loader system for implant needles
US6530875B1 (en) 2000-10-20 2003-03-11 Imagyn Medical Technologies, Inc. Brachytherapy seed deployment system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460592A (en) * 1994-01-24 1995-10-24 Amersham Holdings, Inc. Apparatus and method for making carrier assembly for radioactive seed carrier
US6450937B1 (en) * 1999-12-17 2002-09-17 C. R. Bard, Inc. Needle for implanting brachytherapy seeds
US6450938B1 (en) * 2000-03-21 2002-09-17 Promex, Llc Brachytherapy device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1377342A2 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223226B2 (en) 2004-11-05 2007-05-29 Nuclear Consultants Group, Inc. Brachytherapy needle and methods for assembling same
WO2011079220A1 (en) * 2009-12-23 2011-06-30 Medi-Physics, Inc. Brachytherapy kit
WO2011079168A1 (en) * 2009-12-23 2011-06-30 Medi-Physics, Inc. Plugless brachytherapy needle
CN104688283A (en) * 2015-03-17 2015-06-10 无锡市人民医院 Accurately-positioning minimally-invading planter

Also Published As

Publication number Publication date
US6554760B2 (en) 2003-04-29
EP1377342A4 (en) 2006-11-29
US20020049411A1 (en) 2002-04-25
EP1377342A2 (en) 2004-01-07
WO2003028808A3 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
US6554760B2 (en) Pre-loaded needle assembly
US6949064B2 (en) Brachytherapy seed deployment system
US6450937B1 (en) Needle for implanting brachytherapy seeds
US8140169B2 (en) Induction heating for the delivery of thermal therapy
JP4746182B2 (en) Method, system and kit for implanting articles
US20030225437A1 (en) Device for retaining material
US6402677B1 (en) Brachytherapy seed needle with window
US7131942B2 (en) Brachytherapy seed deployment system
EP2968969B1 (en) Brachytherapy seed insertion and fixation system
US8641593B2 (en) Brachytherapy element transfer system
US20090105584A1 (en) Fiducial marker deployment system using single stick neeedle and method of use
US8944984B2 (en) Radiation/drug delivery method and apparatus
US20070078291A1 (en) Needle assembly with enhanced steerability
KR20240026919A (en) Radiation therapy applicator with vertical or angled radial distribution
RU2791920C2 (en) Radioactive grains and applicators
JP2001120569A (en) Marking device for endoscope

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ PH PL PT RO SD SE SG SI SK SL TJ TM TR TT TZ UG UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZW AM AZ BY KG KZ MD TJ TM AT BE CH CY DE DK ES FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REEP Request for entry into the european phase

Ref document number: 2001274522

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001274522

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001274522

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP